Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

What Causes Cancer?

Cutaneous Manifestations of Internal Malignancy

Cancer Research

Investigating the Molecular Mechanisms of Cancer

Insights into Oncofertility

What is Immunochemotherapy?

The Biochemistry of Breast Cancer Screening

Cancer Diagnosis

Hot vs Cold: the differences between tumor types

Metastatic Migration in Cancer may be Influenced by Metabolism

Cancer Screening Considerations: Balancing the Benefits and Risks

See more featured articles »

Effects of Social and Economic Deprivation on Cancer Mortality

Insight into Cancer Vaccines

What Role do Biobanks Play in Cancer Research?

Using Biomarkers to Detect Cancer

Overview of Cell Viability and Cytotoxicity

Is Cancer a Metabolic Disorder?

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Cancer Classification

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Pediatric Cancer

Cancer Glossary

The Cancer Cell Surface Proteome as a Therapeutic Target

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer Epidemiology

What is Merkel Cell Carcinoma?

Why are Cancer Cell Lines Useful?

What is Cancer?

Microfluidic cancer treatment screen combined with flow cytometry

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Targeted Cancer Therapies

Caring for a Loved One with Cancer

Assay for Monitoring and Treating Malignant Brain Tumors

Hypoxia Markers and Their Importance

Living with Cancer Pain

Cancer Symptoms

Transforming Cancer Care through Genomic Testing

Cancer Prevention: Lowering your Risk

British Pioneers in Cancer Biology

TARDIS: The Improved Method of Detecting Breast Cancer

The Effects of Cancer on Family Life

Cancer Management

Cancer History

What is Tumorigenesis?

Extracellular Vesicles as Floating Cancer Biomarkers

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Pain Management

Cancer Pathophysiology

What is the Tumor Microenvironment?

Secondary Lung Cancer

What is Cancer of Unknown Primary?

Cancer Pain

Myc Mutations and Cancer

Cancer Prognosis

Acidosis and Tumor Progression

Secondary Brain Cancer

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

CDK9 and Cancer

Latest Cancer News and Research

Scientists find a way to boost the body's natural viral defenses

Washington State University researchers have discovered how to "crank up" a natural defense system in the body to combat viral infection, potentially opening a new door for treating virus infections, cancer, neurological disorders and other diseases.

20 Oct 2026

Scientists discover immune pathway behind radiation-induced lung damage

Researchers at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the country, have uncovered an immune pathway that may contribute to radiation-related lung damage and have identified a potential strategy to block it.

20 Oct 2026

Targeted ultrasound waves safely reduce delusions in people with schizophrenia

Targeting a deep brain region with sound waves may safely reduce delusions in people with schizophrenia and schizoaffective disorder, initial study results show.

20 Oct 2026

Routine liver cancer screening extends lives for patients with alcohol-associated cirrhosis

A new study led by investigators from Mass General Brigham found routine liver cancer screening to be cost-effective and life-extending for individuals with alcohol-associated cirrhosis, even when their annual risk of developing liver cancer is less than half the risk level guiding current screening recommendations.

20 Oct 2026

New program helps high-risk children improve sun protection behaviors

Children of parents who have melanoma, a serious type of skin cancer that starts in the cells that make pigment, have twice the lifetime risk of developing the disease themselves.

20 Oct 2026

Discovery of new bacteria opens fresh avenues for prostate cancer research

University of East Anglia researchers have discovered the genetic blueprints of 18 new bacterial species collected from prostate cancer patients.

20 Oct 2026

Advanced AI tool estimates biological age and predicts cancer survival from face photos

Researchers are using AI tools to analyze simple facial photographs to determine key indicators of a person's health. Mass General Brigham researchers built FAHR-Face (Foundation Artificial Intelligence for Health Recognition), a large AI foundation model trained on over 40 million face images.

20 Oct 2026

New gene-editing platform gives doctors control over cell therapies

An Australian clinician-led research team has developed a gene-editing platform that could give doctors more control over cell therapies, making them more practical for patients with complex immune conditions.

20 Oct 2026

New PET imaging approach detects nearly all kidney cancer lesions

A new PET imaging approach detected 97.9% of lesions in clear cell renal cell carcinoma (ccRCC), potentially giving clinicians a more complete picture of the location and extent of a patient's disease, according to research presented today at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM'26).

20 Oct 2026

New study identifies protein factor linked to chronic liver disease

The mechanisms that cause the world's most common chronic liver disease — Metabolic dysfunction-associated steatotic liver disease (MASLD) — to develop and progress are not still fully understood.

20 Oct 2026

Not all ultra-processed foods show the same cancer risk

Ultra-processed foods show varied associations with colorectal cancer, underscoring the need for precise research on diet quality and cancer risk factors.

20 Oct 2026

New AI model detects hidden diseases in routine CT scans

When analyzed by a new artificial intelligence model developed at Penn Medicine, CT scans reveal much about a patient's health beyond the specific condition they were originally ordered for, according to a new study published in NPJ Digital Medicine.

20 Oct 2026

Study explores potential breast cancer benefits of neurokinin receptor antagonists

Neurokinin receptor (NKR) antagonists are already widely used for treating menopausal hot flashes, representing a highly effective nonhormone treatment.

20 Oct 2026

Researchers use mitochondrial uncouplers to target breast cancer metastasis

Mitochondrial serine catabolic pathway (MSCP), also called serine, glycine, and one-carbon metabolism, is essential for cancer cells to produce amino acids, one-carbon units, and reducing equivalents.

19 Oct 2026

Blood pressure drug losartan boosts metabolism by stimulating brown fat

Losartan, a drug commonly prescribed for high blood pressure, boosts brown adipose tissue or "brown fat" activity and enhances its metabolism, according to a preclinical study by Weill Cornell Medicine, Rockefeller University and Memorial Sloan Kettering Cancer Center researchers.

19 Oct 2026

UCL study reveals broad mortality risks faced by ADHD individuals

For the study, published in JAMA Network Open, the researchers conducted a systematic review and meta-analysis of 19 studies that included data from close to 16 million study participants on three continents.

19 Oct 2026

MUSC study reveals gender shift in adolescent vaping trends

For decades, boys and men were more likely than their female peers to use nicotine. But a new study from MUSC shows that among U.S. adolescents, that pattern has reversed for vaping.

19 Oct 2026

Lack of primary care increases early breast cancer death risk

People who are marginalized or lack access to a primary care provider are at greater risk of early death from newly diagnosed (de novo) metastatic breast cancer, according to research in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.260156.

19 Oct 2026

Miro1 protein linked to insulin resistance in type 2 diabetes

A protein called Miro1 found at elevated levels in the skeletal muscle of people with Type 2 diabetes may contribute to insulin resistance, potentially making it a target for future treatments that help the body regulate blood sugar, according to a study published today in Nature Communications.

19 Oct 2026

First patient dosed in Phase 1 clinical trial of new cancer drug

On August 18, 2026, in Japan, the Department of New Experimental Therapeutics and Early-Phase 1 Drug Development Service at Kansai Medical University Hospital, led by Professor Toshio SHIMIZU, administered DS1025 to the first patient worldwide as part of a global, multicenter First-in-Human Phase 1 clinical trial sponsored by Daiichi Sankyo.

19 Oct 2026